- Significant retail expansion through major Canadian pharmacy chains
- New distribution partnership with Kohl & Frisch
- Integration with pharmacy benefit managers MyRxCare and Greenshield Canada
NuGen Medical Devices Inc. (TSXV: NGMD), a leading developer of needle-free devices, has announced the expansion of its InsuJet™ needle-free insulin delivery device across Canada. This expansion follows Health Canada's approval and its nationwide introduction in November 2024. InsuJet™ is now available through major pharmacy retailers such as London Drugs, Pattison Food Group, Pure Integrative Pharmacies, Imperial Distributors, Shoppers Drug Mart, and McKesson Canada.
Beginning mid-April 2025, new partnerships with Kohl & Frisch and a national retail partner will further enhance the availability of InsuJet™. These partnerships are aimed at increasing the accessibility of this innovative insulin administration technology to Canadians living with diabetes.
As part of these efforts, the company's Canadian distributor, Sol-Millennium, has collaborated with MyRxCare and Greenshield Canada to provide pharmacy adjudication and educational support. Sol-Millennium continues its partnership with I Challenge Diabetes, a Canadian non-profit organization promoting diabetes awareness and support, with CEO Chris Jarvis actively advocating for the InsuJet™.
Engaging with healthcare professionals is a priority for Sol-Millennium, which will attend several key pharmacy and healthcare conferences across Canada in 2025. This engagement aims to highlight the benefits of the InsuJet™ device, promoting its adoption among endocrinologists, primary care physicians, pharmacists, Certified Diabetes Educators (CDEs), and researchers.
